Correlation Between TWEAK Serum Level and HTLV-1 Proviral Load in HAM/TSP
Viral Immunology · 2024
DOI: 10.1089/vim.2024.0070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, 2024. Verfasst von Nafiseh Taheri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology (Bacteriology & Virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Viral Load, Human T-lymphotropic virus 1, Paraparesis, Tropical Spastic, Proviruses. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Human T-cell lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), the main neurological manifestation of HTLV-I, is a chronic inflammatory disease. Viral-host interaction and host genetics are two important contributors to the development of the HAM/TSP. This study was conducted to measure the serum level of tumor necrosis factor-alpha-like weak inducer of apoptosis (TWEAK) by ELISA method in three groups of participants including 34 HAM/TSP patients (HAM/TSP), 35 asymptomatic HTLV-1 carriers (ACs), and 20 healthy controls (HCs). Also, the titer of the proviral load in two groups of HAM/TSP and ACs was assessed by the real-time polymerase chain reaction (PCR). The statistical results showed that, there is no significant difference between the three groups in TWEAK cytokine level (p = 0.667). Also, there was no significant difference in proviral load titer between groups of HAM/TSP and ACs (p = 0.08). Furthermore, no significant difference was observed between proviral load and TWEAK cytokine concentration between groups of HAM/TSP and ACs. Our findings showed that despite the inflammatory nature of HAM/TSP disease, the expression level of TWEAK in HAM/TSP patients is not significantly different from the groups of ACs and HCs. Therefore, the involvement of other factors in causing HAM/TSP is not unexpected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology (Bacteriology & Virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
- Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.
- Department of Radiologic Technology, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran.
- Immunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Saeedeh Ebrahimi
Zitieren
APA
Taheri, N., Fani, M., Khanbabaei, H., Vahidi, Z., Zemorshidi, F., Boostani, R., Rafatpanah, H., & Ebrahimi, S. (2024). Correlation Between TWEAK Serum Level and HTLV-1 Proviral Load in HAM/TSP. Viral Immunology. https://doi.org/10.1089/vim.2024.0070
Vancouver
Taheri N, Fani M, Khanbabaei H, Vahidi Z, Zemorshidi F, Boostani R, et al. Correlation Between TWEAK Serum Level and HTLV-1 Proviral Load in HAM/TSP. Viral Immunology. 2024. doi:10.1089/vim.2024.0070
BibTeX
@article{Taheri2024,
author = {Taheri, Nafiseh and Fani, Mona and Khanbabaei, Hashem and Vahidi, Zohreh and Zemorshidi, Fariba and Boostani, Reza and Rafatpanah, Houshang and Ebrahimi, Saeedeh},
title = {Correlation Between TWEAK Serum Level and HTLV-1 Proviral Load in HAM/TSP},
journal = {Viral Immunology},
year = {2024},
doi = {10.1089/vim.2024.0070}
}
EUVIMED